{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T05:05:47Z","timestamp":1776488747982,"version":"3.51.2"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Division of Lung Diseases of the NHLBI and the Cardiovascular Medical Education and Research Fund held a workshop to discuss how to leverage the anticipated scientific output from the recently launched \u201cRedefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics\u201d (PVDOMICS) program to develop newer approaches to pulmonary vascular disease. PVDOMICS is a collaborative, protocol-driven network to analyze all patient populations with pulmonary hypertension to define novel pulmonary vascular disease (PVD) phenotypes. Stakeholders, including basic, translational, and clinical investigators; clinicians; patient advocacy organizations; regulatory agencies; and pharmaceutical industry experts, joined to discuss the application of precision medicine to PVD clinical trials. Recommendations were generated for discussion of research priorities in line with NHLBI Strategic Vision Goals that include: (1) A national effort, involving all the stakeholders, should seek to coordinate biosamples and biodata from all funded programs to a web-based repository so that information can be shared and correlated with other research projects. Example programs sponsored by NHLBI include PVDOMICS, Pulmonary Hypertension Breakthrough Initiative, the National Biological Sample and Data Repository for PAH, and the National Precision Medicine Initiative. (2) A task force to develop a master clinical trials protocol for PVD to apply precision medicine principles to future clinical trials. Specific features include: (a) adoption of smaller clinical trials that incorporate biomarker-guided enrichment strategies, using adaptive and innovative statistical designs; and (b) development of newer endpoints that reflect well-defined and clinically meaningful changes. (3) Development of updated and systematic variables in imaging, hemodynamic, cellular, genomic, and metabolic tests that will help precisely identify individual and shared features of PVD and serve as the basis of novel phenotypes for therapeutic interventions.<\/jats:p>","DOI":"10.1164\/rccm.201701-0150ws","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T15:24:34Z","timestamp":1492788274000},"page":"1661-1670","source":"Crossref","is-referenced-by-count":64,"title":["Enhancing Insights into Pulmonary Vascular Disease Through a Precision Medicine Approach. A Joint NHLBI\u2013Cardiovascular Medical Research and Education Fund Workshop Report"],"prefix":"10.1093","volume":"195","author":[{"given":"John H.","family":"Newman","sequence":"first","affiliation":[{"name":"Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Rich","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven H.","family":"Abman","sequence":"additional","affiliation":[{"name":"Pediatric Heart and Lung Center, University of Colorado, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Division of Cardiology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Barnard","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald J.","family":"Beck","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond L.","family":"Benza","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, Allegheny Health Network, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd M.","family":"Bull","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Y.","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung J.","family":"Chun","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Declan","family":"Doogan","sequence":"additional","affiliation":[{"name":"Independent Consultant, Palm Coast, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Dupuis","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Montreal, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serpil C.","family":"Erzurum","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, and"},{"name":"Department of Medicine, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Frantz","sequence":"additional","affiliation":[{"name":"Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Geraci","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Indiana University, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter","family":"Gillies","sequence":"additional","affiliation":[{"name":"Independent Consultant and Pharmaceutical Physician, Half Moon Bay, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Gladwin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Gray","sequence":"additional","affiliation":[{"name":"Pulmonary Hypertension Association, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna R.","family":"Hemnes","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy S.","family":"Herbst","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, Yale University, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian F.","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Hill","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Tufts University, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn M.","family":"Horn","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cornell University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendall","family":"Hunter","sequence":"additional","affiliation":[{"name":"College of Engineering and Applied Science, University of Colorado, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Cheng","family":"Jing","sequence":"additional","affiliation":[{"name":"FuWai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Johns","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Kaul","sequence":"additional","affiliation":[{"name":"Division of Cardiology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Kawut","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Lahm","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Indiana University, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A.","family":"Leopold","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg D.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Mathai","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vallerie V.","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos D.","family":"Michelakis","sequence":"additional","affiliation":[{"name":"University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D.","family":"Nathan","sequence":"additional","affiliation":[{"name":"Advanced Lung Disease Program, Inova Fairfax Hospital, Falls Church, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Nichols","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Cincinnati Children\u2019s Hospital, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grier","family":"Page","sequence":"additional","affiliation":[{"name":"RTI International, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Rabinovitch","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, Stanford, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Rich","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Rischard","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Arizona, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Rounds","sequence":"additional","affiliation":[{"name":"Department of Medicine and Laboratory Medicine, Brown University, Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjiv J.","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor F.","family":"Tapson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Lowy","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular and Renal Products, Food and Drug Administration, Office of Drug Evaluation I, Office of New Drugs, Food and Drug Administration Silver Spring, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman","family":"Stockbridge","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular and Renal Products, Food and Drug Administration, Office of Drug Evaluation I, Office of New Drugs, Food and Drug Administration Silver Spring, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Weinmann","sequence":"additional","affiliation":[{"name":"Division of Lung Diseases, NHLBI, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8733-8327","authenticated-orcid":false,"given":"Lei","family":"Xiao","sequence":"additional","affiliation":[{"name":"Division of Lung Diseases, NHLBI, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"2026032023421134200_bib1","doi-asserted-by":"crossref","first-page":"D4","DOI":"10.1016\/j.jacc.2013.10.025","article-title":"Relevant issues in the pathology and pathobiology of pulmonary hypertension","volume":"62","author":"Tuder","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026032023421134200_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023421134200_bib3","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/CIRCULATIONAHA.112.092924","article-title":"National Heart, Lung, and Blood Institute workshop: improving outcomes for pulmonary vascular disease","volume":"125","author":"Robbins","year":"2012","journal-title":"Circulation"},{"key":"2026032023421134200_bib4","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1164\/rccm.201006-0869WS","article-title":"Strategic plan for lung vascular research: an NHLBI-ORDR workshop report","volume":"182","author":"Erzurum","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023421134200_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1164\/rccm.201311-1954ST","article-title":"An official American Thoracic Society statement: pulmonary hypertension phenotypes","volume":"189","author":"Dweik","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023421134200_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl J Med"},{"key":"2026032023421134200_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1164\/rccm.201605-0905PP","article-title":"Molecular medicine of pulmonary arterial hypertension from population genetics to precision medicine and gene editing","volume":"195","author":"Austin","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023421134200_bib8","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.03.540","article-title":"Management of pulmonary arterial hypertension","volume":"65","author":"McLaughlin","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026032023421134200_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"key":"2026032023421134200_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ahj.2009.11.028","article-title":"Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed","volume":"159","author":"Macchia","year":"2010","journal-title":"Am Heart J"},{"key":"2026032023421134200_bib11","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026032023421134200_bib12","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/CIRCULATIONAHA.106.674002","article-title":"Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension","volume":"118","author":"Ghofrani","year":"2008","journal-title":"Circulation"},{"key":"2026032023421134200_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/CIRCHEARTFAILURE.113.000983","article-title":"Invasive assessment of pulmonary hypertension: time for a more fluid approach?","volume":"7","author":"Borlaug","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026032023421134200_bib14","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jacc.2012.01.083","article-title":"Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials","volume":"60","author":"Savarese","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026032023421134200_bib15","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.jacc.2009.04.007","article-title":"End points and clinical trial design in pulmonary arterial hypertension","volume":"54","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026032023421134200_bib16","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026032023421134200_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.76.1.135","article-title":"High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy","volume":"76","author":"Rich","year":"1987","journal-title":"Circulation"},{"key":"2026032023421134200_bib18","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"2026032023421134200_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCULATIONAHA.114.013317","article-title":"Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension","volume":"131","author":"Hemnes","year":"2015","journal-title":"Circulation"},{"key":"2026032023421134200_bib20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1164\/rccm.201508-1678OC","article-title":"Critical genomic networks and vasoreactive variants in idiopathic pulmonary arterial hypertension","volume":"194","author":"Hemnes","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023421134200_bib21","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1164\/rccm.201501-0196OC","article-title":"Endothelin-1 pathway polymorphisms and outcomes in pulmonary arterial hypertension","volume":"192","author":"Benza","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023421134200_bib22","article-title":"PVDOMICS protocol website"},{"key":"2026032023421134200_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.11-0404","article-title":"Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension","volume":"141","author":"Gabler","year":"2012","journal-title":"Chest"},{"key":"2026032023421134200_bib24","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/art.39220","article-title":"Adverse events in connective tissue disease-associated pulmonary arterial hypertension","volume":"67","author":"Rhee","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026032023421134200_bib25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1164\/rccm.201507-1456OC","article-title":"Comparison of treatment response in idiopathic and connective tissue disease-associated pulmonary arterial hypertension","volume":"192","author":"Rhee","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023421134200_bib26","author":"United States Institute of Medicine"},{"key":"2026032023421134200_bib27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJMe1515172","article-title":"Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors","volume":"374","author":"Taichman","year":"2016","journal-title":"N Engl J Med"},{"key":"2026032023421134200_bib28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature"},{"key":"2026032023421134200_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/CIRCRESAHA.111.258541","article-title":"The emerging paradigm of network medicine in the study of human disease","volume":"111","author":"Chan","year":"2012","journal-title":"Circ Res"},{"key":"2026032023421134200_bib30","doi-asserted-by":"crossref","first-page":"26094","DOI":"10.1038\/srep26094","article-title":"Deep patient: an unsupervised representation to predict the future of patients from the electronic health records","volume":"6","author":"Miotto","year":"2016","journal-title":"Sci Rep"},{"key":"2026032023421134200_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"2026032023421134200_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1183\/09031936.00107108","article-title":"End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?","volume":"34","author":"Peacock","year":"2009","journal-title":"Eur Respir J"},{"key":"2026032023421134200_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/01.CIR.63.1.152","article-title":"Quantitative analysis of the pulmonary wedge angiogram in congenital heart defects: correlation with hemodynamic data and morphometric findings in lung biopsy tissue","volume":"63","author":"Rabinovitch","year":"1981","journal-title":"Circulation"},{"key":"2026032023421134200_bib34","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/eurheartj\/ehr160","article-title":"Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward","volume":"32","author":"Lau","year":"2011","journal-title":"Eur Heart J"},{"key":"2026032023421134200_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00441-002-0616-x","article-title":"Calcitonin receptor-like receptor: identification and distribution in human peripheral tissues","volume":"310","author":"Hagner","year":"2002","journal-title":"Cell Tissue Res"},{"key":"2026032023421134200_bib36","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.113.004136","article-title":"Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments","volume":"128","author":"Zhao","year":"2013","journal-title":"Circulation"},{"key":"2026032023421134200_bib37","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","article-title":"Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy","volume":"58","author":"van de Veerdonk","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026032023421134200_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1086\/681227","article-title":"Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy","volume":"5","author":"Talati","year":"2015","journal-title":"Pulm Circ"},{"key":"2026032023421134200_bib39","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.106.632208","article-title":"Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure","volume":"114","author":"Voelkel","year":"2006","journal-title":"Circulation"},{"key":"2026032023421134200_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/2045-8932.109933","article-title":"Advancing clinical trial design in pulmonary hypertension","volume":"3","author":"Grieve","year":"2013","journal-title":"Pulm Circ"},{"key":"2026032023421134200_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2016.04.012","article-title":"Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future","volume":"164","author":"Lythgoe","year":"2016","journal-title":"Pharmacol Ther"},{"key":"2026032023421134200_bib42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrd4439","article-title":"The biomarkers consortium","volume":"13","author":"Wholley","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"2026032023421134200_bib43","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/cncr.28172","article-title":"I-SPY 2 may change how clinical trials are conducted: researchers aim to accelerate approvals of cancer drugs","volume":"119","author":"Printz","year":"2013","journal-title":"Cancer"},{"key":"2026032023421134200_bib44"},{"key":"2026032023421134200_bib45","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1158\/1078-0432.CCR-12-1818","article-title":"Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial","volume":"19","author":"Blumenschein","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2026032023421134200_bib46"},{"key":"2026032023421134200_bib47","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jacc.2012.03.080","article-title":"The 6-minute walk test as a primary endpoint in clinical trials for pulmonary hypertension","volume":"60","author":"Rich","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026032023421134200_bib48","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.106.618397","article-title":"Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension","volume":"114","author":"Mereles","year":"2006","journal-title":"Circulation"},{"key":"2026032023421134200_bib49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCOUTCOMES.114.001319","article-title":"Building the case for novel clinical trials in pulmonary arterial hypertension","volume":"8","author":"Ryan","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026032023421134200_bib50","article-title":"Molecular imaging of the human pulmonary vascular endothelium in pulmonary hypertension: a phase II safety and proof of principle trial","author":"Harel","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/195\/12\/1661\/67142671\/ajrccm_195_12_1661.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/195\/12\/1661\/67142671\/ajrccm_195_12_1661.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:42:56Z","timestamp":1774064576000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/195\/12\/1661\/8500269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,6,15]]},"published-print":{"date-parts":[[2017,6,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201701-0150ws","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727537343.793531238","asserted-by":"object"}]},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,6]]},"published":{"date-parts":[[2017,6]]}}}